These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7945745)

  • 1. Testmeal responses following m-chlorophenylpiperazine and L-tryptophan in bulimics and controls.
    Brewerton TD; Murphy DL; Jimerson DC
    Neuropsychopharmacology; 1994 Aug; 11(1):63-71. PubMed ID: 7945745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
    Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of serotonin function in anorexia nervosa.
    Brewerton TD; Jimerson DC
    Psychiatry Res; 1996 Apr; 62(1):31-42. PubMed ID: 8739113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache responses following m-chlorophenylpiperazine in bulimics and controls.
    Brewerton TD; Murphy DL; Lesem MD; Brandt HA; Jimerson DC
    Headache; 1992 May; 32(5):217-22. PubMed ID: 1628957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of preloads of differing energy and macronutrient content on eating behavior in bulimia nervosa.
    Rolls BJ; Hetherington MM; Stoner SA; Andersen AE
    Appetite; 1997 Dec; 29(3):353-67. PubMed ID: 9468765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).
    Price LH; Malison RT; McDougle CJ; McCance-Katz EF; Owen KR; Heninger GR
    Neuropsychopharmacology; 1997 Nov; 17(5):342-50. PubMed ID: 9348549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.
    Antonatos S; Galanopoulou P
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro- and macroanalyses of patterns within a meal in anorexia and bulimia nervosa.
    Sunday SR; Halmi KA
    Appetite; 1996 Feb; 26(1):21-36. PubMed ID: 8660030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.
    Bagdy G; Arato M
    Psychopharmacology (Berl); 1998 Apr; 136(4):342-8. PubMed ID: 9600579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-destructiveness and serotonin function in bulimia nervosa.
    Steiger H; Koerner N; Engelberg MJ; Israël M; Ng Ying Kin NM; Young SN
    Psychiatry Res; 2001 Aug; 103(1):15-26. PubMed ID: 11472787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological, hormonal and biochemical changes following carbohydrate bingeing: a placebo controlled study in bulimia nervosa and matched controls.
    Turner MS; Foggo M; Bennie J; Carroll S; Dick H; Goodwin GM
    Psychol Med; 1991 Feb; 21(1):123-33. PubMed ID: 2047488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated.
    Gordon ML; Lipton RB; Brown SL; Nakraseive C; Russell M; Pollack SZ; Korn ML; Merriam A; Solomon S; van Praag HM
    Cephalalgia; 1993 Dec; 13(6):400-5. PubMed ID: 8313453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is migraine related to the eating disorders?
    Brewerton TD; George MS
    Int J Eat Disord; 1993 Jul; 14(1):75-9. PubMed ID: 8339102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa.
    Steiger H; Young SN; Kin NM; Koerner N; Israel M; Lageix P; Paris J
    Psychol Med; 2001 Jan; 31(1):85-95. PubMed ID: 11200963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craving for cocaine in addicted users. Role of serotonergic mechanisms.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Am J Addict; 1997; 6(1):65-73. PubMed ID: 9097873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine.
    Brewerton TD; Murphy DL; Mueller EA; Jimerson DC
    Clin Pharmacol Ther; 1988 Jun; 43(6):605-9. PubMed ID: 3378382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders.
    Novotny S; Hollander E; Phillips A; Allen A; Wasserman S; Iyengar R
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):249-54. PubMed ID: 15132762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.
    Nappi RE; Sances G; Brundu B; De Taddei S; Sommacal A; Ghiotto N; Polatti F; Nappi G
    Hum Reprod; 2005 Dec; 20(12):3423-8. PubMed ID: 16123089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled glucose challenge in bulimia nervosa: psychological effects.
    Blouin AG; Blouin J; Bushnik T; Braaten J; Goldstein C; Sarwar G
    Biol Psychiatry; 1993 Feb; 33(3):160-8. PubMed ID: 8448264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trazodone treatment of bulimia nervosa.
    Solyom L; Solyom C; Ledwidge B
    J Clin Psychopharmacol; 1989 Aug; 9(4):287-90. PubMed ID: 2768544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.